Global
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.29 B
|
Sept. 30, 2024 | USD 95.65 | 1.10% |
|
United States |
|
2 |
USD 2.46 B
|
Oct. 31, 2024 | USD 3.26 | 1.24% |
|
United States |
|
3 |
USD 2.09 B
|
Sept. 30, 2024 | USD 235.80 | -0.17% |
|
United States |
|
4 |
USD 1.25 B
|
Sept. 30, 2024 | USD 61.26 | -2.69% |
|
United States |
|
5 |
USD 983.00 M
|
Sept. 30, 2024 | USD 362.80 | 0.50% |
|
United States |
|
6 |
USD 869.69 M
|
Sept. 27, 2024 | USD 44.75 | -1.32% |
|
United States |
|
7 |
USD 591.18 M
|
Dec. 31, 2023 | USD 7.85 | -1.23% |
|
South Korea |
|
8 |
USD 511.86 M
|
Sept. 30, 2024 | USD 99.01 | 4.67% |
|
United States |
|
9 |
USD 434.90 M
|
Dec. 31, 2023 | USD 0.69 | 2.27% |
|
China |
|
10 |
USD 423.87 M
|
Dec. 31, 2023 | USD 3.37 | 3.57% |
|
China |
|
11 |
USD 410.37 M
|
Sept. 30, 2024 | USD 99.89 | 4.44% |
|
United States |
|
12 |
USD 394.99 M
|
June 30, 2024 | USD 17.28 | 1.26% |
|
Australia |
|
13 |
USD 359.48 M
|
Sept. 30, 2024 | USD 65.65 | -1.41% |
|
United States |
|
14 |
USD 304.81 M
|
Sept. 28, 2024 | USD 79.96 | 0.69% |
|
United States |
|
15 |
USD 296.60 M
|
Sept. 30, 2024 | USD 538.88 | -0.16% |
|
United States |
|
16 |
USD 238.12 M
|
Sept. 30, 2024 | USD 21.93 | -1.62% |
|
United States |
|
17 |
USD 225.54 M
|
Dec. 31, 2023 | USD 15.35 | 4.46% |
|
China |
|
18 |
USD 196.24 M
|
Sept. 30, 2024 | USD 46.27 | -3.11% |
|
Germany |
|
19 |
USD 180.61 M
|
Dec. 31, 2023 | USD 1.09 | 4.04% |
|
China |
|
20 |
USD 150.12 M
|
Dec. 31, 2023 | USD 2.19 | 2.04% |
|
China |
|
21 |
USD 113.15 M
|
Sept. 27, 2024 | USD 138.83 | 2.72% |
|
United States |
|
22 |
USD 107.85 M
|
Dec. 31, 2023 | USD 1.51 | 3.28% |
|
China |
|
23 |
USD 102.04 M
|
Sept. 30, 2024 | USD 0.81 | 0.53% |
|
United States |
|
24 |
USD 100.03 M
|
Dec. 31, 2023 | USD 1.73 | 4.28% |
|
China |
|
25 |
USD 97.53 M
|
Sept. 27, 2024 | USD 148.22 | 1.40% |
|
United States |
|
26 |
USD 86.23 M
|
Dec. 31, 2023 | USD 33.15 | -1.66% |
|
Costa Rica |
|
27 |
USD 77.33 M
|
Dec. 31, 2023 | USD 0.28 | 0.36% |
|
Sweden |
|
28 |
USD 69.89 M
|
Dec. 31, 2023 | USD 4.62 | 5.85% |
|
China |
|
29 |
USD 63.41 M
|
Sept. 30, 2024 | USD 23.55 | -5.80% |
|
United States |
|
30 |
USD 62.32 M
|
March 31, 2024 | USD 9.21 | 3.00% |
|
Japan |
|
31 |
USD 59.90 M
|
Sept. 29, 2024 | USD 41.10 | -7.87% |
|
United States |
|
32 |
USD 58.60 M
|
Dec. 31, 2023 | USD 0.30 | -1.09% |
|
Brazil |
|
33 |
USD 57.86 M
|
Dec. 31, 2023 | USD 38.13 | 0.20% |
|
Italy |
|
34 |
USD 57.62 M
|
Sept. 30, 2024 | USD 16.15 | 7.38% |
|
United States |
|
35 |
USD 50.44 M
|
Dec. 31, 2023 | USD 16.63 | 0.49% |
|
Sweden |
|
36 |
USD 49.96 M
|
Sept. 30, 2024 | USD 3.70 | -8.19% |
|
United States |
|
37 |
USD 46.92 M
|
Dec. 31, 2023 | USD 1.13 | 5.74% |
|
China |
|
38 |
USD 44.42 M
|
Sept. 30, 2024 | USD 17.51 | 0.81% |
|
United States |
|
39 |
USD 42.92 M
|
Dec. 31, 2023 | USD 2.44 | 7.76% |
|
China |
|
40 |
USD 41.92 M
|
Dec. 31, 2023 | USD 36.83 | -2.69% |
|
South Korea |
|
41 |
USD 39.43 M
|
Sept. 30, 2024 | USD 3.14 | -1.57% |
|
United States |
|
42 |
USD 39.12 M
|
Dec. 31, 2023 | USD 29.11 | 3.16% |
|
Germany |
|
43 |
USD 38.94 M
|
Dec. 31, 2023 | USD 0.77 | -0.19% |
|
China |
|
44 |
USD 37.92 M
|
Dec. 31, 2023 | USD 0.23 | 1.46% |
|
United Kingdom |
|
45 |
USD 37.53 M
|
Dec. 31, 2023 | USD 2.67 | 0.76% |
|
Israel |
|
46 |
USD 36.78 M
|
Dec. 31, 2023 | USD 9.23 | 4.58% |
|
China |
|
47 |
USD 36.20 M
|
Dec. 31, 2023 | USD 8.05 | -1.47% |
|
||
48 |
USD 33.52 M
|
Dec. 31, 2023 | USD 9.87 | 0.82% |
|
Spain |
|
49 |
USD 32.28 M
|
Dec. 31, 2023 | USD 2.00 | NA |
|
Belgium |
|
50 |
USD 31.55 M
|
March 31, 2024 | USD 2.68 | -1.35% |
|
Japan |
The Medical Instruments company with the highest Net Cash Used Provided By Financing Activities is Boston Scientific Corporation (NYSE: BSX) at USD 3.29 B.
The Medical Instruments company with the lowest Net Cash Used Provided By Financing Activities is Abbott Laboratories (NYSE: ABT) at USD -5.59 B.
The top 10 Medical Instruments companies the Global by Net Cash Used Provided By Financing Activities are Boston Scientific Corporation, Heart Test Laboratories, Inc., Becton, Dickinson and Company, Bruker Corporation, Stryker Corporation, Enovis Corporation, SD BioSensor, Inc, iRhythm Technologies, Inc., MicroPort Scientific Corporation and Intco Medical Technology Co., Ltd..
The bottom 10 Medical Instruments companies by Net Cash Used Provided By Financing Activities are Abbott Laboratories, Medtronic plc, Thermo Fisher Scientific Inc., Olympus Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Edwards Lifesciences Corporation, DexCom, Inc., ResMed Inc. and Hologic, Inc..